Atlas Trials

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Clinical trial NCT00530920 · COMPLETED

Trial details

NCT number
NCT00530920
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2007-10-01
Primary completion
2008-05-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.